Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Prelude Therapeutics Inc | CEO, Director | Common Stock | 2M | $1.38M | $0.69 | Mar 25, 2025 | Direct |
Prelude Therapeutics Inc | CEO, Director | Common Stock | 552K | $382K | $0.69 | Mar 25, 2025 | By Trust |
Prelude Therapeutics Inc | CEO, Director | Common Stock | 143K | $98.7K | $0.69 | Mar 25, 2025 | Indirect |
Prelude Therapeutics Inc | CEO, Director | Employee Stock Option (right to buy) | 496K | Feb 4, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PRLD | Prelude Therapeutics Inc | Mar 25, 2025 | 1 | $467K | 4 | Mar 27, 2025 | CEO, Director |
PRLD | Prelude Therapeutics Inc | Mar 20, 2025 | 2 | $14.9K | 4 | Mar 24, 2025 | CEO, Director |
PRLD | Prelude Therapeutics Inc | Mar 14, 2025 | 2 | $29.5K | 4 | Mar 18, 2025 | CEO, Director |
PRLD | Prelude Therapeutics Inc | Mar 12, 2025 | 2 | $69.6K | 4 | Mar 14, 2025 | CEO, Director |
PRLD | Prelude Therapeutics Inc | Feb 4, 2025 | 1 | $0 | 4 | Feb 5, 2025 | CEO, Director |
PRLD | Prelude Therapeutics Inc | Dec 31, 2024 | 1 | $6.04K | 4 | Jan 3, 2025 | CEO, Director |
PRLD | Prelude Therapeutics Inc | Dec 30, 2024 | 1 | $12K | 4 | Jan 2, 2025 | CEO, Director |
PRLD | Prelude Therapeutics Inc | Dec 18, 2024 | 2 | $99.3K | 4 | Dec 20, 2024 | CEO, Director |
PRLD | Prelude Therapeutics Inc | Mar 1, 2024 | 1 | $0 | 4 | Mar 4, 2024 | CEO, Director |
PRLD | Prelude Therapeutics Inc | May 24, 2023 | 2 | $9.79K | 4 | May 26, 2023 | CEO, Director |
PRLD | Prelude Therapeutics Inc | May 23, 2023 | 1 | $66.7K | 4 | May 25, 2023 | CEO, Director |
PRLD | Prelude Therapeutics Inc | Feb 7, 2023 | 1 | $0 | 4 | Feb 9, 2023 | CEO, Director |
PRLD | Prelude Therapeutics Inc | Dec 20, 2022 | 1 | $98.4K | 4 | Dec 21, 2022 | CEO, Director |
PRLD | Prelude Therapeutics Inc | Feb 15, 2022 | 1 | $0 | 4 | Feb 17, 2022 | CEO, Director |
PRLD | Prelude Therapeutics Inc | Dec 13, 2021 | 1 | $97K | 4 | Dec 14, 2021 | President, CEO, Director |
PRLD | Prelude Therapeutics Inc | Jul 20, 2021 | 1 | $0 | 4 | Jul 22, 2021 | President, CEO, Director |